iCoreConnect Q1 2021 Revenue Grows 39% and Subscriptions Exceed 12,000

iCoreConnect gross profit percentage was 66% and 57% for the three months ended March 31, 2021 and 2020, respectively

Windermere, FL, May 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — iCoreConnect, Inc. (OTCQB: ICCT), a cloud-based, Software-as-a-Service (SaaS) platform for healthcare business workflow, announced total revenue for Q1 2021 increased by 39%.  The revenue growth is attributed to the increased number of SaaS and Managed Service Provider (MSP) subscriptions compared to the prior year period.  

iCoreConnect provides subscription-based SaaS, Managed IT including MSP, Managed Software-as-a-Service (MSaaS), professional IT and other services.  “We expect the growth rate of our SaaS and MSaaS subscription offerings to grow faster than our professional services and other revenue streams,” cited iCoreConnect President and CEO, Robert McDermott.  “Subscription software and services revenue represented 84% of total revenue for the first quarter of 2021 compared to 80% of revenue for the same period in 2020. Professional services and other revenue represented 16% of total revenue for the first quarter of 2021 compared to 20% of revenue for the same period in 2020.”

Gross profit percentage was 66% and 57% for the three months ended March 31, 2021 and 2020, respectively. In April of this year, iCoreConnect acquired Advantech, a Scottsdale AZ-based MSP and software developer. “Advantech is accretive to our gross margins, profitability and growth, while leveraging our new marketing relationship with the Arizona Dental Association,” explained McDermott. 

About iCoreConnect

iCoreConnect is a cloud-based, Software-as-a-Service (SaaS) platform for healthcare business workflow. The company focuses on increasing profit and operational speed in high-compliance industries. iCoreConnect is most notably known for its innovation in solving healthcare business problems. The company’s philosophy is built on a high level of customer feedback, allowing iCoreConnect to respond to the market’s needs.  iCoreConnect touts a platform of more than a dozen SaaS enterprise solutions and more than 40 agreements with state or regional healthcare associations. iCoreConnect is a member of the prestigious StartUp Health accelerator.

Forward Looking Statements

In this news release, the use of the words “believe,” “could,” “expect,” “may,” “positioned,” “project,” “projected,” “should,” “will,” “would” or similar expressions are intended to identify forward-looking statements that represent the Company’s current judgment about possible future events. The Company believes these judgments are reasonable, but these statements are not guarantees of any events or financial results, and actual results may differ materially due to a variety of important factors.

Cile Spelce
[email protected]



Ultimus CEO Gary Tenkman Elected to ICI Board of Governors

Mutual Fund Industry Benefits from His Years of Financial Services Experience

CINCINNATI, May 19, 2021 (GLOBE NEWSWIRE) — Ultimus Fund Solutions® (Ultimus®) announced today that Gary Tenkman, CEO of Ultimus, has been elected to serve on the Board of Governors of the Investment Company Institute (ICI) to complete the three year term of Ultimus Co-Founder Bob Dorsey, who retired at the end of March. ICI represents regulated funds globally, including mutual funds and ETFs, and the Board of Governors is responsible for setting ICI policies and overseeing activities to represent funds and their shareholders.

Tenkman commented, “I am honored to be elected to the ICI Board of Governors. It will be a pleasure and privilege to contribute to the Board’s initiatives and help to promote the interests of shareholders, investment advisers, trustees, and the industry as a whole. At Ultimus, we have a unique perspective on the industry given that we service large institutional asset managers along with entrepreneurial advisers bringing new products to market with particular insight on what those managers are thinking of during what continues to be a quickly evolving environment. I look forward to working with other industry leaders on significant issues facing registered investment vehicles as this business grows and evolves.”

Tenkman has been at the helm of Ultimus as CEO since 2018. He previously served as President and COO since joining Ultimus in 2014. Under Tenkman’s leadership, the firm has experienced tremendous growth as a result of new client mandates, mergers and acquisitions, all while maintaining industry-leading client satisfaction ratings. Currently, the firm services over $350 billion in AUA, providing fund administration for a broad range of fund structures such as actively managed funds, ETFs, tender offer, closed end and interval funds, and services for a wide range of private asset fund structures. Tenkman has more than 30 years of experience in the financial services industry, including in various leadership positions at Citi in their investor services business.

Ultimus is active within the ICI organization, with staff serving on many of its committees and advisory panels. Ultimus is also the leading provider of series trust solutions that represent 100+ fund families with over 240 funds of which those trusts are also ICI members. In total, Ultimus currently services over 1300 registered and private funds.

About Ultimus

Ultimus Fund Solutions (Ultimus) is a leading tech-enabled provider of full-service fund administration, accounting, and investor solutions to support the launching and servicing of registered funds, private funds, and public plans. The company also offers customized structures designed for the unique needs of pensions, endowments, foundations, and other large institutions. Ultimus has a deep commitment to excellence, achieved through investments in best-in-class technology, organization-wide cyber security efforts, and hiring professional staff.

Headquartered in Cincinnati, Ohio with servicing groups in other major cities such as Chicago, New York and Denver, Ultimus employs more than 700 seasoned accountants, attorneys, paralegals, application developers, fund administrators, compliance specialists, and many others with years of experience in the financial services industry. Servicing over 1,300 total traditional and alternative funds, Ultimus helps investment managers and fund families flourish in today’s increasingly sophisticated and dynamic investment landscape. For more information, visit www.ultimusfundsolutions.com.

About ICI

The Investment Company Institute (ICI) is the leading association representing regulated funds globally, including mutual funds, exchange-traded funds (ETFs), closed-end funds, and unit investment trusts (UITs) in the United States, and similar funds offered to investors in jurisdictions worldwide. ICI seeks to encourage adherence to high ethical standards, promote public understanding, and otherwise advance the interests of funds, their shareholders, directors, and advisers. ICI’s members manage total assets of US$26.1 trillion in the US, serving more than 100 million shareholders, and US $8.2 trillion in assets in other jurisdictions. ICI carries out its international work through ICI Global, with offices in London, Hong Kong, and Washington, DC. To learn more, visit www.ici.org.

12850688 5/18/2021



Genco Shipping & Trading Limited to Acquire Two Modern, Fuel-Efficient Ultramax Vessels

Fixed Two Additional Vessels on Period Time Charters, Securing Cash Flows at Attractive Levels

NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco”) today announced that it has entered into agreements to acquire two 2022-built 61,000 dwt Ultramax vessels to be constructed at Dalian Cosco KHI Ship Engineering Co. Ltd. (DACKS). The vessels are expected to be delivered to Genco in January 2022.

The purchases mark the fifth and sixth high specification, fuel-efficient Ultramax vessels that Genco has agreed to acquire since December 2020, doubling its core Ultramax presence over that time. Genco intends to fund the acquisition from cash on the balance sheet on a low leverage basis.

Genco also announced that it has capitalized on the strong market to fix two additional vessels on period time charters to secure cash flows as part of its portfolio approach to fixture activity:

  • Baltic Bear (2010-built Capesize) fixed at $32,000 per day for 10 to 14 months
  • Genco Vigilant (2015-built Ultramax) fixed at $17,750 per day for 11 to 13 months beginning in October 2021

John C. Wobensmith, Chief Executive Officer, commented, “This latest acquisition continues the expansion of our fleet at an attractive point in the drybulk cycle as asset values continue to trail the strong freight rate environment leading to attractive returns on capital. Built at a first-class shipyard, we expect these two Ultramaxes will seamlessly integrate into our in-house commercial platform while reducing our carbon footprint as they replace older, less fuel-efficient vessels. These vessels continue our growth trajectory within the key Ultramax sector while improving the age profile of our asset base. Furthermore, acquiring these vessels on a low leverage basis enables us to continue to drive down our financial leverage and cash flow breakeven rate while augmenting our operating leverage. Growth together with deleveraging serve as primary components of our comprehensive value strategy as we continue to progress towards full execution in the months ahead.”

About Genco Shipping & Trading Limited

Genco Shipping & Trading Limited transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes. Capesize vessels represent our major bulk vessel category and the other vessel classes, including Ultramax and Supramax vessels, represent our minor bulk vessel category. Our major bulk vessels are primarily used to transport iron ore and coal, while our minor bulk vessels are primarily used to transport grains, steel products and other drybulk cargoes such as cement, scrap, fertilizer, bauxite, nickel ore, salt and sugar. This approach of owning ships that transport both major and minor bulk commodities provide us with exposure to a wide range of drybulk trade flows. As of May 19, 2021, Genco Shipping & Trading Limited’s fleet consists of 17 Capesize, nine Ultramax and 14 Supramax vessels with an aggregate capacity of approximately 4,368,000 dwt and an average age of 10.4 years.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements use words such as “anticipate,” “budget,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. These forward-looking statements are based on our management’s current expectations and observations. Included among the factors that, in our view, could cause actual results to differ materially from the forward looking statements contained in this report are the following: (i) the completion of definitive documentation with respect to charters; (ii) charterers’ compliance with the terms of their charters in the current market environment; (iii) completion of documentation for vessel transactions and the performance of the terms thereof by sellers of vessels and us; and (iv) other factors listed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent reports on Form 8-K and Form 10-Q. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:

Apostolos Zafolias
Chief Financial Officer
Genco Shipping & Trading Limited
(646) 443-8550



Nxt-ID, Inc. Announces Investor Webcast to Discuss the Financial Results for the Three Months Ended March 31, 2021 and to Provide a General Corporate Update

Oxford, Connecticut, May 19, 2021 (GLOBE NEWSWIRE) — Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company” or “Nxt-ID”), a provider of technology products and services for healthcare applications, announces financial results for the three months ended March 31, 2021.

Financial highlights and results from the first quarter of 2021 included:

  • Revenue for the three months ended March 31, 2021 was approximately $2.4 million, compared to approximately $3.7 million for the same 2020 period.
  • Gross profit for the three months ended March 31, 2021 was approximately $1.6 million, compared to approximately $2.8 million for the same 2020 period.
  • Operating expenses for the three months ended March 31, 2021 were approximately $2.3 million, compared to approximately $1.8 million for the same 2020 period.
  • Operating loss for the three months ended March 31, 2021 was approximately $783,000; for the three months ended March 31, 2020, operating income was approximately $1.0 million.
  • Non-GAAP Operating income for the three months ended March 31, 2021, adjusted for depreciation, amortization and other non-cash charges, was approximately $69,000, compared to approximately $1.3 million for the same 2020 period.
  • Non-GAAP net loss for the three months ended March 31, 2021, adjusted for depreciation, amortization and other non-cash charges was approximately $312,000, compared to net income of approximately $860,000 for the same 2020 period.
  • Net cash used in operating activities for the three months ended March 31, 2021 was approximately $1.0 million, as compared to approximately $0.5 million in cash provided by operating activities for the three months ended March 31, 2020.
  • Repaid approximately $5.5 million in term debt during the three months ended March 31, 2021.
  • Cash balance at March 31, 2021 was approximately $8.5 million.

“Our first quarter 2021 operating results reflected a positive trend and rebound in our markets as customers that had been reluctant to commit to larger purchases during the COVID-19 pandemic during 2020 began ordering at pre-pandemic levels,” said Vin Miceli, Chief Executive Officer of Nxt-ID. “I’m pleased with the Company’s overall performance in the first quarter of 2021, which reinforces the belt-tightening we made before the pandemic hit. I’m especially pleased with the significant term debt repayments the Company has made thus far in 2021, which approximate $8.8 million and which will save the Company approximately $1.1 million in cash interest expense on an annual basis.”

Added Mr. Miceli: “Halfway into the second quarter of 2021, the positive business trends are continuing.  I look forward to providing additional commentary on the second quarter’s results, updating our shareholders and providing some additional context regarding our Company’s path forward.”

Full financial results and Management’s Discussion and Analysis can be found in the Company’s Form 10-Q for the three months ended March 31, 2021, which was filed with the Securities and Exchange Commission (“SEC”) on May 17, 2021, and can be found at https://www.sec.gov/Archives/edgar/data/1566826/000121390021027209/f10q0321_nxtidinc.htm

The management team will host an investor webcast to discuss the financial results for the three months ended March 31, 2021 and update shareholders on general corporate developments. The webcast will commence on Thursday, May 20, 2021 at 4:10 PM (ET). Shareholders, investors and interested parties wanting to participate in the webcast must use this link to register prior to the event: https://edge.media-server.com/mmc/p/7xx9xuqa.

For those wishing to participate by telephone, please use the following dial-in credentials:

US/CANADA Participant Toll-Free Dial-In Number: (877) 644-5287
US/CANADA Participant International Dial-In Number: (281) 973-6282
Conference ID: 9447459

About Nxt-ID, Inc.


Nxt-ID, Inc.
 (NASDAQ: NXTD) provides technology products and services for healthcare applications. The Company has extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, sensor technologies and healthcare applications. Through its subsidiary, LogicMark LLC, Nxt-ID is a manufacturer and distributor of non-monitored and monitored personal emergency response systems sold through dealers/distributors and the United States Department of Veterans Affairs. Learn more about Nxt-ID at www.nxt-id.comFor Nxt-ID corporate information contact: [email protected].

Forward-Looking Statements for Nxt-ID: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company’s business strategy. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company’s ability to implement its long range business plan for various applications of its technology; the Company’s ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company’s technology; the Company’s ability to maintain its Nasdaq listing for its common stock; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the SEC.

“Non-GAAP Operating Income” is defined as operating income as reported plus depreciation expense, amortization of intangibles and stock compensation expense. Non-GAAP Operating Income is commonly used by management and investors as an indicator of operating performance and liquidity. Non-GAAP Operating Income is not considered a measure of financial performance under GAAP and it should not be considered as an alternative to net income.

Media Contacts:

Vincent S. Miceli CEO/CFO
[email protected]



REPAY Further Streamlines B2B Payments with Sage Accounts Payable Automation

REPAY Further Streamlines B2B Payments with Sage Accounts Payable Automation

Vendor Payments Automation added to the Sage 100 integration to reduce the costs of paying vendors, while lowering risks of costly manual errors and fraud

ATLANTA–(BUSINESS WIRE)–Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY), a leading provider of vertically-integrated payment solutions, today announced the launch of its Vendor Payments Automation solution into Sage 100, which will enable businesses to seamlessly pay vendors in a simple, secure way while also reducing unnecessary costs. This supplements REPAY’s existing integrations with Sage X3 and Sage 300 solutions.

The new integration is available through APS Payments, a REPAY company and a leading provider of omni-channel B2B integrated payment solutions. Extending REPAY’s integration into Sage rounds out the comprehensive, full-service vendor enablement with both AR and AP payments automation. Businesses can streamline processes and boost their bottom lines by simply paying bills more efficiently and effectively.

“With the addition of accounts payable solutions to our Sage 100 integration, we continue our commitment to reducing costs and optimizing the transaction process for businesses,” says Darin Horrocks, SVP, B2B, REPAY. “Intentionally designed with simplicity in mind, a single integration eliminates unnecessary manual processes while increasing revenue and security – a true win-win for business users on Sage.”

The Vendor Payments Automation solution supports creation and approval of payment groups, vendor group management, and invoicing, along with automatic reconciliation and custom reporting within Sage 100.

About REPAY

REPAY provides integrated payment processing solutions to verticals that have specific transaction processing needs. REPAY’s proprietary, integrated payment technology platform reduces the complexity of electronic payments for merchants, while enhancing the overall experience for consumers and businesses.

Investor Relations Contact for REPAY:

[email protected]

Media Relations Contact for REPAY:

Kristen Hoyman

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Technology Other Technology

MEDIA:

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Diversified Pipeline to Psychedelic Revival

NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) — via InvestorWireTryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, “Wall Street Unicorns in Process of Changing the Healthcare Landscape,” please visit: https://nnw.fm/QOAcO

Before 1970, promising research was being conducted on the potential therapeutic effects of a broad category of psychedelic drug compounds, including substances such as psilocybin, DMT (dimethyltryptamine), LSD (lysergic acid diethylamide) and MDMA (methylenedioxymethamphetamine) — and then the Controlled Substance Act was signed into law, which labeled those substances as drugs of abuse with no medical value. The severely limited research conducted thereafter continued to demonstrate the potential of these compounds to provide therapeutic value, particularly for notoriously difficult diseases such as depression, addiction, PTSD and others.

In the past few years, the relatively unattended field of psychedelic therapeutics is seeing a revival of activity and excitement, spawning innovative approaches and creating valuable companies in the process. Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) is one of the exciting new companies to enter the public domain, bringing a diversified pipeline and de-risked strategy that should usher the company right into phase 2 clinical trials. A public company since its IPO in December of 2020, Tryp aims to become a leader in the healthcare and drug development industries.

About Tryp Therapeutics Inc.

Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and safety profiles for the treatment of rare and other diseases with unmet medical needs. Tryp’s psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders. Tryp’s lead PFN drug candidate is TRP-8802 for the treatment of fibromyalgia, a chronic pain syndrome estimated to affect more than five million people in the United States. The company is also preparing to initiate a phase 2a clinical study for eating disorders in partnership with the Dr. Jennifer Miller at the University of Florida. In addition to its PFN program, Tryp is developing TRP-1001, an oral formulation of razoxane for the treatment of soft-tissue sarcoma. Soft-tissue sarcomas are a rare and diverse group of tumors that account for about 1% of all cancers in adults and 7% in children. Based on the prevalence of soft-tissue sarcomas in the United States, Tryp believes it is a rare disease and that TRP-1001 should qualify for orphan drug status.

For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYP are available in the company’s newsroom at https://ibn.fm/TRYPF.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.

NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork



Ecolab Wins 2021 Edison Award for COVID-19 Innovation

Ecolab’s Sink & Surface Cleaner Sanitizer Recognized for Ability to Kill COVID-19 Virus in Just 15 Seconds While Simplifying Foodservice Cleaning Processes

ST. PAUL, Minn., May 19, 2021 (GLOBE NEWSWIRE) — Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, received a 2021 Edison Award in the COVID-19 Innovation category for its Sink & Surface Cleaner Sanitizer – the first product registered by the EPA to kill the COVID-19 virus in just 15 seconds. This versatile cleaner sanitizer is the only product proven to kill the COVID-19 virus in 15 seconds that is approved for use on food contact surfaces without requiring a rinse – saving foodservice operators time and resources.

“We’re honored to receive an Edison Award for our Sink & Surface Cleaner Sanitizer as we continue to develop solutions designed to combat the COVID-19 virus and other public health and food safety challenges,” said Timothy Mulhere, executive vice president and president of Global Institutional & Specialty Services, the Ecolab group that serves the hospitality, foodservice and food retail industries. “Our innovations are key to helping our foodservice customers and other businesses meet heightened expectations for cleanliness and more stringent public health and hygiene protocols. Together, we are advancing cleaner, safer, more efficient practices and building consumer confidence.”

Ecolab’s Sink & Surface Cleaner Sanitizer is a concentrated no-rinse, 2-in-1 cleaner and sanitizer designed for use on any hard, non-porous food contact surface – from food prep areas and the third sink in the kitchen to guest tables. The product, available for use in spray bottle, bucket, wipe, third sink or electrostatic spray applications, simplifies restaurant hygiene procedures by combining an effective cleaner and sanitizer into one solution without the need to rinse between cleaning and sanitizing or before contact with food surfaces. In addition to the COVID-19 virus, this cleaner sanitizer is proven to kill Norovirus, influenza and the common cold virus.

Sink & Surface Cleaner Sanitizer is one of the innovative solutions powering the Ecolab Science Certified™ program. This comprehensive, science-based program is built on Ecolab’s long-standing experience in helping keep healthcare facilities clean, bringing the same expertise used in hospitals to the places people eat, stay and shop. Ecolab Science Certified combines this healthcare expertise with hospital disinfectants and food-contact sanitizers approved for use during the COVID-19 pandemic, public health and food safety protocols and training, and periodic auditing. Consumers can now visit everyday places with confidence by looking for the Ecolab Science Certified seal.

One of nine COVID-19 innovations recognized this year, Ecolab’s Sink & Surface Cleaner Sanitizer was chosen as the 2021 Bronze Edison Award winner by a panel of judges comprised of more than 3,000 senior business executives and academics. The Edison Awards have recognized and honored some of the most innovative new products, services and business leaders in the world since 1987.

“We were very impressed by the level of collaboration and discovery in this year’s entries,” said Edison Universe Executive Director Frank Bonafilia. “Somehow, while facing the unprecedented challenges of this global pandemic, companies around the world figured out how to work safely and smartly and still innovate at an award-winning level.”

For more information about Ecolab’s Sink & Surface Cleaner Sanitizer or to order, contact your local Ecolab representative or visit ecolab.com/sinksurfacesanitizer. To learn more about the Edison Awards, visit edisonawards.com.

About Ecolab
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services. With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and personalized service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve operational efficiencies and sustainability for customers in the food, healthcare, hospitality and industrial markets in more than 170 countries around the world. www.ecolab.com

Follow us on LinkedIn at Ecolab, Twitter @ecolab, Instagram at @Ecolab Inc or Facebook at @Ecolab.

About the Edison Awards

Over the last 34 years, being recognized with an Edison Award has become one of the highest accolades a product can receive in the name of innovation success. The awards are named after Thomas Alva Edison (1847-1931) whose inventions, new product development methods, and innovative achievements changed the world. The Edison Awards are operated by Edison Universe, a 501cs non-profit organization with the mission of recognizing, honoring and fostering innovations and innovators, and are hosted in Fort Myers, Florida.

Contacts:

Mesa Denny, Ecolab
+1 651 250 4724
[email protected]

May 19, 2021

(ECL-P)

EPA Reg. No. 1677-259 and 1677-260



Nautilus, Inc. to Participate in Upcoming Virtual Investor Conferences

Nautilus, Inc. to Participate in Upcoming Virtual Investor Conferences

VANCOUVER, Wash.–(BUSINESS WIRE)–
Nautilus, Inc. (the “Company”) (NYSE: NLS) today announced that Jim Barr, the Company’s Chief Executive Officer, and Aina Konold, the Company’s Chief Financial Officer, will participate in the following virtual investor conferences:

Craig-Hallum 18th Annual Institutional Investor Conference

Management will participate in virtual one-on-one and small group meetings on Wednesday, June 2, 2021. There will be no formal presentation.

William Blair 41st Annual Growth Stock Conference

Management will participate in a fireside chat on Thursday, June 3, 2021 at 12:00 pm PT and participate virtually in one-on-one and small group meetings.

About Nautilus, Inc.

Headquartered in Vancouver, Washington, Nautilus, Inc. (NYSE:NLS) is a global technology driven fitness solutions company that believes everyone deserves a fit and healthy life. With a brand portfolio including Bowflex®, Schwinn®, JRNY® and Nautilus®. Nautilus, Inc. is committed to build a healthier world, one person at a time. Nautilus, Inc. uses the investor relations page of its website (www.nautilusinc.com/investors) to make information available to its investors and the market.

Investor Relations:

John Mills

ICR, LLC

646-277-1254

[email protected]

Media Contacts:

John Fread

Nautilus, Inc.

360-859-5815

[email protected]

Carey Kerns

The Hoffman Agency

503-754-7975

[email protected]

KEYWORDS: Washington United States North America

INDUSTRY KEYWORDS: Retail Health Technology Other Technology Fitness & Nutrition Specialty Biotechnology

MEDIA:

Live Ventures Extends Stock Buyback Program

LAS VEGAS, May 19, 2021 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE), a diversified holding company, previously announced that its Board of Directors has extended the stock buyback program (initiated in February, 2018) until June 1, 2024. The program authorizes the company to buy up to $10 million of its outstanding shares of common stock on the open market at prevailing prices. Of that amount, approximately $6.7 million remains available as of today for this purpose.

“A part of our job is strategic deployment of capital for optimum company growth and shareholder value,” said Jon Isaac, Live Ventures’ President and Chief Executive Officer. “Repurchasing stock can be a prudent and productive use of capital, along with investing in our portfolio companies and paying down debt. The stock buyback program has offered attractive returns on cash generated by our profitable businesses.”        

Since inception of the stock buyback program in 2018, 418 thousand shares of LIVE stock have been repurchased at an average price of $7.70 and, as of the last trading day prior to the issuance of this press release, the company’s stock closed at $41.75 per share. Repurchases under the buyback program are made in accordance with the Securities Exchange Act of 1934, as amended, which sets restrictions on the method, timing, price and volume of open market repurchases.

“The Board and I believe that the purchase of our common stock is an affirmation of the company’s business prospects and financial health,” Isaac added. “We look forward to making additional purchases, as strategically warranted, thereby reaffirming our confidence in Live Ventures’ future growth.”

Repurchases under the program are funded by cash on hand and cash generated by operations of the company’s core businesses.

About Live Ventures

Originally incorporated in 1968, Live Ventures Incorporated is a diversified holding company with several wholly owned subsidiaries and a strategic focus on acquiring profitable companies that have demonstrated a strong history of earnings power. Through its subsidiary Marquis Industries, the company manufactures and sells residential and commercial carpets primarily in North America. Marquis Industries also designs, sources and sells hard-surface flooring. Through its subsidiary Precision Marshall, the company manufactures and sells steel in four product categories: Deluxe Alloy Plate, Deluxe Tool Steel Plate, Precision Ground Flat Stock, and Drill Rod. Through its subsidiary Vintage Stock, an award-winning entertainment retailer, the company sells new and pre-owned movies, classic and current generation video games and systems, music on CD & LP, collectible comics, books, toys, and more. Vintage Stock, through its stores and website, ships product worldwide directly to the customer’s doorstep. Through its subsidiary Precision Industries, the company sells premium tool steels and specialty alloys. Through its subsidiary ApplianceSmart, the company sells new major household appliances in the United States through a company-owned retail store in Columbus, Ohio operating under the name ApplianceSmart®. All Live Ventures companies are rooted in their local communities where they contribute to the local economy and serve as responsible corporate neighbors.

Contact:
Live Ventures Incorporated
Tim Matula, Investor Relations
(425) 836-9035
[email protected]
http://liveventures.com
Source: Live Ventures Incorporated



IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION

Vancouver, B.C. and Boston, MA, May 19, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (“Lighthouse”).      

The Company is on target to demonstrate the i/Blue Imaging System™ in private meetings during the American Urology Association (AUA) meeting to be held in early September. The product will showcase updates to meet performance criteria against competitive products and improvements made to the design for manufacturing.

The updated product design also incorporates changes intended to meet critical verification requirements established through benchmark testing of competitive systems and feedback from preliminary meetings with the FDA.

Additional testing and specification development has been focused on contrast-agent-induced fluorescence and the ability to replicate clinical observations in a bench-level study.  Sensitivity of the system can now be fully demonstrated with the test methods that have been established.           

“As the process moves forward, we’re creating the potential for additional IP that will make the i/Blue Imaging System unique and innovative and strengthen the demand for blue light cystoscopy (BLC). Patients have been hearing about the superiority of blue light over white light to identify bladder cancer tumors and are searching for facilities that provide it,” commented Jim Hutchens, Imagin’s president and CEO.

Under Imagin’s stock option plan, the Company has granted incentive stock options in lieu of cash compensation to a consultant to acquire an aggregate of 25,000 common shares at a price of $0.66 CA per share, for a period of five years from the date of grant.

“We appreciate the continued support of our investors as we continue to move forward,” Jim Hutchens added.


About Imagin Medical

Imagin Medical is a surgical imaging company focused on advancing new methods of visualizing cancer during minimally invasive procedures. The Company believes its first product, the i/Blue™ Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting cancer for removal, helping to reduce recurrence rates. The Company’s initial focus is bladder cancer. Learn more at www.imaginmedical.com.


Forward-Looking Statements


Information set forth in this news release contains forward-looking statements. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward- looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information.
Specifically, there is no assurance the Company’s imaging system will work in the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.


Contact:

Jim Hutchens President & CEO

Telephone: 833-246-2446

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]